Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice
Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice
The prevalence of extended spectrum beta-lactamase (ESBL) producing bacteria found in urine
 sample cultures has been increasing over the past decades.

 The study hypothesis is to assess the clinical and microbiological outcome of pivmecillinam
 treatment of ESBL producing E. coli and K. Pneumoni, as well as to observe the clinical and
 microbiological outcome of the same group of bacteria treated with other antiinfectious
 agents.

 Samples are gathered in primary care setting.
Inclusion Criteria:

 - All patients were urinary sample taken in a primary care setting shows significant growth
 of ESBL producing E. coli.

 Above age 16.

 Exclusion Criteria:

 - Sample from patients in hospital care or living in nursing home facilities. Inability to
 understand and sign information leaflet.